Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aparna Chhibber

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Genome Biology|September 19, 2015
An ensemble approach to accurately detect somatic mutations using SomaticSeqLi Tai Fang, Pegah Tootoonchi Afshar, Aparna Chhibber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2012
A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101R Michael Baldwin, Kouros Owzar, Hitoshi Zembutsu, et al.
Human Mutation|April 12, 2017
Lessons from the CAGI-4 Hopkins clinical panel challengeJohn-Marc Chandonia, Aashish Adhikari, Marco Carraro, et al.
NPJ Precision Oncology|July 18, 2024
Baseline biomarkers of efficacy and on-treatment immune-profile changes associated with bempegaldesleukin plus nivolumabHelen Gogas, Shruthi Ravimohan, Antara Datta, et al.
Nature Medicine|March 7, 2025
Nivolumab plus chemotherapy or ipilimumab in gastroesophageal cancer: exploratory biomarker analyses of a randomized phase 3 trialKohei Shitara, Yelena Y Janjigian, Jaffer Ajani, et al.
Clinical Pharmacology and Therapeutics|July 25, 2020
A Microdose Cocktail to Evaluate Drug Interactions in Patients with Renal ImpairmentDaniel A Tatosian, Ka Lai Yee, Zufei Zhang, et al.
Future Oncology (London, England)|October 8, 2025
Plain language summary of publication: Comparing nivolumab and neoadjuvant chemotherapy with placebo and neoadjuvant chemotherapy in participants with newly diagnosed estrogen receptor-positive breast cancer in the CheckMate 7FL clinical trialSherene Loi, Roberto Salgado, Giuseppe Curigliano, et al.
Nature Medicine|January 21, 2025
Neoadjuvant nivolumab and chemotherapy in early estrogen receptor-positive breast cancer: a randomized phase 3 trialSherene Loi, Roberto Salgado, Giuseppe Curigliano, et al.
Cancer Discovery|February 26, 2026
A tumor-promoting inflammatory SPP1+ macrophage-IL-6-CRP axis drives immune dysfunction in bladder cancerMichelle A Tran, Byuri Angela Cho, Sudeh Izadmehr, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Genome Biology|September 19, 2015
An ensemble approach to accurately detect somatic mutations using SomaticSeqLi Tai Fang, Pegah Tootoonchi Afshar, Aparna Chhibber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2012
A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101R Michael Baldwin, Kouros Owzar, Hitoshi Zembutsu, et al.
Human Mutation|April 12, 2017
Lessons from the CAGI-4 Hopkins clinical panel challengeJohn-Marc Chandonia, Aashish Adhikari, Marco Carraro, et al.
NPJ Precision Oncology|July 18, 2024
Baseline biomarkers of efficacy and on-treatment immune-profile changes associated with bempegaldesleukin plus nivolumabHelen Gogas, Shruthi Ravimohan, Antara Datta, et al.
Nature Medicine|March 7, 2025
Nivolumab plus chemotherapy or ipilimumab in gastroesophageal cancer: exploratory biomarker analyses of a randomized phase 3 trialKohei Shitara, Yelena Y Janjigian, Jaffer Ajani, et al.
Clinical Pharmacology and Therapeutics|July 25, 2020
A Microdose Cocktail to Evaluate Drug Interactions in Patients with Renal ImpairmentDaniel A Tatosian, Ka Lai Yee, Zufei Zhang, et al.
Future Oncology (London, England)|October 8, 2025
Plain language summary of publication: Comparing nivolumab and neoadjuvant chemotherapy with placebo and neoadjuvant chemotherapy in participants with newly diagnosed estrogen receptor-positive breast cancer in the CheckMate 7FL clinical trialSherene Loi, Roberto Salgado, Giuseppe Curigliano, et al.
Nature Medicine|January 21, 2025
Neoadjuvant nivolumab and chemotherapy in early estrogen receptor-positive breast cancer: a randomized phase 3 trialSherene Loi, Roberto Salgado, Giuseppe Curigliano, et al.
Cancer Discovery|February 26, 2026
A tumor-promoting inflammatory SPP1+ macrophage-IL-6-CRP axis drives immune dysfunction in bladder cancerMichelle A Tran, Byuri Angela Cho, Sudeh Izadmehr, et al.
Pageof 2